1月13日,第43届摩根大通医疗保健会议(JP Morgan Healthcare Conference)如期召开。昨天,医药魔方已经报道了强生、BMS、吉利德、辉瑞、再生元等制药巨头披露的最新公司发展动态和2025年战略。今天,医药魔方继续报道默沙东、拜耳、礼来、罗氏、诺华等跨国公司在过去一年的进展和未来规划。▌默沙东:将推出20个“重磅炸弹”,上调肿瘤业务收入预期在过去几年,默沙东首席执行官...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.